Neuroblastoma and insulin-like growth factor system. New insights and clinical perspectives

European Journal of Pediatrics

Volumn 156, Issue 4, 1997, Pages 256-261

  Cianfarani, Stefano ^a   Rossi, Paola ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Cancer; IGF; IGFBP; Neuroblastoma

Indexed keywords

ANTINEOPLASTIC AGENT; OCTREOTIDE; PEPTIDE; RECEPTOR BLOCKING AGENT; RETINOIC ACID; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN;

CELL DIFFERENTIATION; CELL PROLIFERATION; CHILD; EMBRYO; HUMAN; NEUROBLASTOMA; PRIORITY JOURNAL; REVIEW;

ANTINEOPLASTIC AGENTS; CELL TRANSFORMATION, NEOPLASTIC; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INFANT, NEWBORN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; NEUROBLASTOMA; SOMATOMEDINS;

EID: 0030980001     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004310050595     Document Type: Review

References (65)

1. Baker J, Liu JP, Robertson E, Efstratiadis A (1993) Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75:73-82
2. Beckwith JB, Perrin EV (1963) In situ neuroblastomas: a contribution to the natural history of neural crest tumours. Am J Pathol 43:1089-1097
3. Bernardini S, Cianfarani S, Spagnoli A, Annicchiarico-Petruzzelli M, Melino G, Massoud R, Boscherini B, Finazzi-Agrò A, Rosenfeld RG, Federici G (1994) Expression and down-regulation by retinoic acid of IGF binding protein-2 and -4 in medium from human neuroblastoma cells. J Neuroendocrinol 6:409-413
4. Bernardini S, Cianfarani S, Pianca C, Massoud R, Germani D, Federici M, Melino G (1995) Insulin-like growth factor binding protein-I serum levels in neuroblastoma. Clin Chem Enzym Comms 6:359-363
5. Blakesley VA, Kalebic T, Helman LJ, Stannard B, Faria TN, Roberts CT, LeRoith D (1996) Tumorigenic and mitogenic capacities are reduced in transfected fibroblasts expressing mutant insulin-like growth factor (IGF)-I receptors. The role of Tyrosine residues 1250, 1251, and 1316 in the carboxy-terminus of the IGF-I receptor. Endocrinology 137:410-417
6. Brodeur GM, Fong C (1989) Molecular biology and genetics of human neuroblastoma. Cancer Genet Cytogenet 41:153-174
7. Brodeur GM, Castleberry RP (1993) Neuroblastoma. In: Pizzo PA, Poplack DG (eds) Principles and practice in pediatric oncology, 2nd edn. J.B. Lippincott, Philadelphia, pp 739-767
8. Brodeur GM, Green AA, Hayes FA, Williams KJ, Williams-DL, Tsiatis AA (1981) Cytogenetic features of human neuroblastoma and cell lines. Cancer Res 41:4678-4686
9. Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM (1984) Amplification of N-myc in untreated human neuroblastoma correlates with advanced disease stage. Science 224:1121-1124.
10. Carlsen NLT (1992) Neuroblastoma epidemiology and pattern of regression. Am J Pediatr Hematol/Oncol 14:103-110
11. Ceda GP, Fielder PJ, Henzel WJ, Louie A, Donovan SM, Hoffman AR, Rosenfeld RG (1991) Differential effects of insulin-like growth factor (IGF)-I and IGF-II on the expression of IGF binding proteins (IGFBPs) in a rat neuroblastoma cell line: isolation and characterization of two forms of IGFBP-4. Endocrinology 128:2815-2824
12. Cheng NC, Roy NV, Chan A, Beitsma M, Westerveld A, Speleman F, Versteeg R (1995) Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35-36 region, only one of which is associated with N-myc amplification. Oncogene 10:291-297
13. Cianfarani S, Holly JMP (1989) Somatomedin-binding proteins: what role do they play in the growth process? Eur J Pediatr 149:76-79
14. Cianfarani S, Germani D, Rossi P, Spagnoli A, Mercanti D (1996) IGF-I exerts a dual function in human neuroblastoma cells, regulating both proliferation and differentiation. J Endocrinol Invest (in press)
15. Daughaday WH (1990) The possible autocrine/paracrine and endocrine roles of insulin-like growth factors of human tumors. Endocrinology 127:1-4
16. El-Badry OM, Romanus JA, Helman LJ, Cooper MJ, Rechler MM, Israel MA (1989) Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor-II. J Clin Invest 84:829-839
17. El-Badry OM, Helman LJ, Chatten J, Steinberg SM, Evans AE, Israel MA (1991) Insulin-like growth factor II-mediated proliferation of human neuroblastoma. J Clin Invest 87:648-657
18. Favrot MC, Combaret V, Goillot E, Lutz P, Frappaz D, Thiesse P, Thyss A, Dolbeau D, Bouffet E, Tabone E, Philip T (1991) Expression of integrin receptors on 45 clinical neuroblastoma specimens. Int J Cancer 49:347-355
19. Fontana JA, Burrows-Mezu A, Clemmons DR, LeRoith D (1991) Retinoid modulation of insulin-like growth factor-binding proteins and inhibition of breast carcinoma proliferation. Endocrinology 128:1115-1122
20. Frost VJ, Macaulay VM, Wass JAH, Holly JMP (1993) Proteolytic modification of insulin-like growth factor-binding proteins: comparison of conditioned media from human cell lines, circulating proteases and characterized enzymes. J Endocrinol 138:545-554
21. Giudice LC (1992) Insulin-like growth factors and ovarian follicular development. Endocr Rev 13:641-669
22. Hart IR, Saini A (1992) Biology of tumour metastasis. Lancet 339:1453-1457
23. Hedborg F, Holmgren L, Sandstedt B, Ohlsson R (1994) The cell type-specific IGF2 expression during early human development correlates to the pattern of overgrowth and neoplasia in the Beckwith-Wiedemannn syndrome. Am J Pathol 145:802-817
24. Hoehner JC, Hedborg F, Wiklund HJ, Olsen L, Pahlman S (1995) Cellular death in nueroblastoma: in situ correlation of apoptosis and bcl-2 expression. Int J Cancer 62:19-24
25. Holly JMP, Wass JAH (1989) Insulin-like growth factors; autocrine, paracrine or endocrine? New perspectives of the somatomedin hypothesis in the light of recent developments. J Endocrinol 122:611-618
26. Hossenlopp P, Segovia B, Lassarre C, Roghani M, Bredon M, Binoux M (1990) Evidence of enzymatic degradation of insulin-like growth factor binding proteins in the 150 kD complex during pregnancy. J Clin Endocrinol Metab 71:797-805
27. Irving JA, Lala PK (1995) Functional role of cell surface integrins on human trophoblast cell migration: regulation by TGF-β, IGF-II, and IGFBP-I. Exp Cell Res 217:419-427
28. Isoai A, Ueno Y, Giga-Hama Y, Goto H, Kumagai H (1992) A novel Arg-Gly-Asp containing peptide specific for platelet aggregation and its effect on tumor metastasis: a possible mechanism of RGD peptide-mediated inhibition of tumor metastasis. Cancer Lett 65:259-264
29. Knudson AG, Strong LC (1972) Mutation and cancer: neuroblastoma and pheochromocytoma. Am J Hum Genet 24:thinsp:514-522
30. Kohl NE, Kanda N, Schreck RR, Bruns G, Latt SA, Gilbert F, Alt FW (1983) Transposition and amplification of oncogene-related sequences in human neuroblastomas. Cell 35:359-367
31. Langford KS, Miell JP (1993) The insulin-like growth factor-I/ binding protein axis: physiology, pathophysiology, and therapeutic manipulation. Eur J Clin Invest 23:503-516
32. LeRoith D, Baserga R, Helman L, Roberts CT (1995) Insulin-like growth factors and cancer. Ann Intern Med 122:54-59
33. LeRoith D, Werner H, Beitner-Johnson D, Roberts CT (1995) Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 16:143-163
34. Leventhal PS, Randolph AE, Vesbit TE, Schenone A, Windebank AJ, Feldman EL (1995) Insulin-like growth factor-II as a paracrine growth factor in human neuroblastoma cells. Exp Cell Res 221:179-186
35. Li X-S, Chen J-C, Sheikh S, Shao Z-M, Fontana JA (1994) Retinoic acid inhibition of insulin-like growth factor I stimulation of c-fos mRNA levels in a breast carcinoma cell line. Exp Cell Res 211:68-73
36. Lonning PE, Hall K, Aakvaag A, Lien EA (1992) Influence of tamoxifen on plasma levels of insulin-like growth gactor I and insulin-like growth factor binding protein I in breast cancer patients. Cancer Res 52:4719-4723
37. Macaulay VM (1992) Insulin-like growth factors and cancer. Br J Cancer 65:311-320
38. Martin DM, Feldman EL (1993) Regulation of insulin-like growth factor-II expression and its role in autocrine growth of human neuroblastoma cells. J Cell Physiol 155:290-300
39. Matsumoto K, Gaetano C, Daughaday WH, Thiele CJ (1992) Retinoic acid regulates insulin-like growth factor Il expression in a neuroblastoma cell line. Endocrinology 130:3669-3676
40. Matthay KK (1995) Neuroblastoma: a clinical challenge and biologic puzzle. CA-Cancer J Clin 45:179-192
41. Mattsson MEK, Enberg G, Ruusala A-I, Hall K, Pahlman S (1986) Mitogenic response of human SH-SY5Y neuroblastoma cells to insulin-like growth factor I and II is dependent on the stage of differentiation. J Cell Biol 102:1949-1954
42. Miale TD, Kirpekar K (1994) Neuroblastoma stage IV-S. Med Oncol 11:89-100
43. Morison IM, Becroft DM, Taniguchi T, Woods CG, Reeve AE (1996) Somatic overgrowth associated with overexpression of insulin-like growth factor II. Nature Med 2:311-316
44. Pahlman S, Ruusala A-I, Abrahamsson L, Odelstad L, Nilsson K (1983) Kinetics and concentration effects of TPA-induced differentiation of cultured human neuroblastoma cells. Cell Differ 12:165-170
45. Pahlman S, Meyerson G, Lindgren E, Schalling M, Johansson I (1991) Insulin-like growth factor I shifts from promoting cell division to potentiating maturation during neuronal differentiation. Proc Natl Acad Sci USA 88:9994-9998
46. Peverali FA, Orioli D, Tonon L, Ciana P, Bunone G, Negri M, Della Valle G (1996) Retinoic acid-induced growth arrest and differentiation of neuroblastoma cells are counteracted by N-myc and enhanced by max overexpressions. Oncogene 12:457-462
47. Philip T (1992) Overview of current treatment of neuroblastoma. Am J Pediatr Hematol/Oncol 14:97-102
48. Reeve AE, Eccles MR, Wilkins RJW, Bell GI, Millow LJ (1985) Expression of insulin-like growth factor-II transcripts in Wilms' tumour. Nature 317:258-260
49. Reeve JG, Kirby LB, Brinkman A, Hughes SA, Schwander J, Blechen M (1992) Insulin-like growth factor-binding protein gene expression and protein production by human tumour cell lines. Int J Cancer 51:818-821
50. Resnicoff M, Abraham D, Yutanawiboonchai W, Rotman HL, Kajstura J, Rubin R, Zoltick P, Baserga R (1995) The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo. Cancer Res 55:2463-2469
51. Rubin R, Baserga R (1995) Biology of disease. Insulin-like growth factor-I receptor. Lab Invest 73:311-331
52. Schofield PN, Lee A, Hill DJ, Cheetham JE, James D, Stewart C (1991) Tumour suppression associated with expression of human insulin-like growth factor II. Br J Cancer 63:687-692
53. Schwab M, Alitalo K, Klempnauer KH, Varmus HE, Bishop JM, Gilbert F, Brodeur G, Goldstein M, Trent JM (1983) Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour: Nature 305:245-248
54. Scott J, Cowell J, Robertson ME, Priestley LM, Wadey R, Hopkins B, Pritchard J, Bell GI, Rall LB, Graham CF, Knott TJ (1985) Insulin-like growth factor II gene expression in Wilms'tumour and embryonic tissues. Nature 317:260-262
55. Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY, Hammond D (1985) Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastoma. N Engl J Med 313:1111-1116
56. Shimada H, Stram DO, Chatten J, Joshi VV, Hachitanda Y, Brodeur GM, Lukens JN, Matthay KK, Seeger RC (1995) Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis. J Natl Cancer Inst 87:1470-1476
57. Shimasaki S, Ling N (1991) Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5, -6) Prog Growth Factor Res 3:243-266
58. Sporn MB, Roberts AB (1985) Autocrine growth factors and cancer. Nature 313:745-747
59. Sturm MA, Conover CA, Pham H, Rosenfeld RG (1989) Insulin-like growth factor receptors and binding protein in rat neuroblastoma cells. Endocrinology 124:388-396
60. Sullivan KA, Castle VP, Hanash SM, Feldman EL (1995) Insulin-like growth factor II in the pathogenesis of human neuroblastoma. Am J Pathol 147:1790-1798
61. Sumantran VN, Feldman EL (1993) Insulin-like growth factor-I regulates c-myc and GAP-43 messenger ribonucleic acid expression in SH-SY5Y human neuroblastoma cells. Endocrinology 132:2017-2023
62. Thiele CJ, Reynolds CP, Israel MA (1985) Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma. Nature 313:404-406
63. Thompson CB (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-1462
64. Ueno T, Suita S, Zaizen Y (1993) Retinoic acid induces insulin-like growth factor II expression in a neuroblastoma cell line. Cancer Lett 71:177-182
65. Yee D, Favoni RE, Lebovic GS, Lombana F, Powell DR, Reynolds CP, Rosen N (1990) Insulin-like growth factor I expression by tumors of neuroectodermal origin with the t(11;22) chromosomal translocation. J Clin Invest 86:1806-1814